Regenxbio Inc (RGNX)

Quick ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash	US$ in thousands	34,522	53,045	68,600	70,091	96,952	118,544	121,374	191,873	345,209	228,387	257,072	291,482	338,426	93,220	94,222	69,411	69,514	79,594	55,142	55,852
Short-term investments	US$ in thousands	279,578	311,455	346,800	403,409	468,248	498,456	560,626	572,927	504,091	305,113	335,928	365,018	184,074	196,580	244,978	287,189	330,486	337,506	394,558	388,448
Receivables	US$ in thousands	24,790	28,043	21,380	18,861	28,082	32,549	37,500	27,022	32,439	46,017	44,394	41,039	42,999	122,116	42,876	44,522	38,148	19,175	9,679	8,372
Total current liabilities	US$ in thousands	130,272	127,346	117,893	112,334	130,434	123,548	114,556	119,937	130,472	106,771	91,554	83,961	81,447	63,613	40,203	31,789	33,676	31,345	24,661	21,390
Quick ratio		2.60	3.08	3.70	4.38	4.55	5.26	6.28	6.60	6.76	5.43	6.96	8.31	6.94	6.48	9.50	12.62	13.01	13.92	18.63	21.16

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($34,522K + $279,578K + $24,790K) ÷ $130,272K
= 2.60

The quick ratio of Regenxbio Inc has displayed fluctuations over the past eight quarters. The quick ratio, which measures the company's ability to meet its short-term obligations using its most liquid assets, ranged from a low of 2.57 in Q4 2023 to a high of 4.06 in Q2 2022.

Generally, a quick ratio above 1 indicates that the company has enough liquid assets to cover its current liabilities. Regenxbio's quick ratios have consistently been well above 1 over the period, indicating a strong ability to meet short-term obligations.

The declining trend from Q2 2022 to Q4 2023 may suggest a decrease in the company's liquid assets relative to its current liabilities. However, the ratios still remain at healthy levels, with the latest ratio of 2.57 in Q4 2023 indicating that Regenxbio continues to have more than enough liquid assets to cover its short-term liabilities.

Overall, while there has been some variability in the quick ratio, Regenxbio has maintained a strong liquidity position throughout the periods analyzed.